Pasqal to Go Public via \$2B SPAC Deal: Investor-Focused Deep Dive
Pasqal to Go Public via \$2 Billion SPAC Deal with Bleichroeder Acquisition Corp II
Key Highlights
- Pasqal, a global leader in neutral atom quantum computing, has entered into a definitive business combination agreement with Bleichroeder Acquisition Corp II, a SPAC.
- Transaction values Pasqal at \$2 billion pre-money, with an expected pro forma market capitalization of approximately \$2.6 billion.
- Over \$600 million gross proceeds expected for Pasqal, including \$289 million from Bleichroeder’s trust, \$200 million in convertible financing, and \$158 million cash on Pasqal’s balance sheet.
- Convertible financing anchored by sponsor-affiliated investor Inflection Point, BPIfrance Large Venture, and new institutional investors.
- Pasqal is a pure play neutral atom quantum computing company with 7 quantum computers deployed, more than any other pure play neutral atom quantum computing company worldwide.
- Pasqal co-founded by Nobel Prize Laureate Alain Aspect; deep scientific leadership including Antoine Browaeys, winner of the 2025 John Stewart Bell Prize.
- Key partnerships with IBM and NVIDIA, with industry clients including Sumitomo, LGE, CMA CGM, Thales, OVHcloud, among others.
- Pasqal reported approximately 100% unaudited revenue growth and has \$80 million in booked and awarded business, representing multi-year customer contracts.
- Strong sovereign backing from France, with a strategic vision to accelerate quantum technology commercialization, quantum advantage, and global growth.
- Transaction expected to close in second half of 2026, subject to regulatory and shareholder approvals.
Transaction Details and Financial Impact
- The deal is structured as a business combination agreement, positioning Pasqal to be listed on Nasdaq. Dual listing on Euronext Paris is also targeted.
- Pasqal will receive over \$600 million in gross proceeds, which is significant for its expansion, R&D, and commercialization efforts.
- \$200 million in convertible financing is secured, giving Pasqal a robust financial runway.
- The combination creates a strong balance sheet, with Pasqal’s cash position enhanced by both the SPAC and the convertible round.
Commercial Strength and Technology Leadership
- Pasqal is recognized for pioneering neutral atom quantum computers, with 7 systems already deployed and 3 more in production.
- The company is trusted by leading industry players, including IBM (Pasqal is part of the IBM Quantum Network) and NVIDIA.
- Pasqal serves more than 25 commercial customers and partners globally, with a proven track record in optimization, simulation, and AI applications.
- Pasqal employs over 275 people, including 70 PhDs, indicating strong scientific and technical capabilities.
- Pasqal’s ability to ramp up to 13 quantum processing units (QPUs) per annum across facilities in France and Canada (subject to staffing and parts availability), positions it for scalable growth.
Strategic Importance and Shareholder Sensitivities
- French sovereign backing through equity shareholding and strategic partnerships provides unique geopolitical and financial support.
- Pasqal’s rapid growth, solid contracts, and high-profile partnerships could make the shares highly attractive to investors seeking exposure to quantum computing.
- The transaction is subject to multiple approvals (regulatory, shareholder, SEC review, and Nasdaq listing), and any delays or failures could affect share values.
- Risks include competition, technical challenges, possible failure to achieve commercialization, potential need for additional financing, and reliance on strategic partners.
- Shareholders should note forward-looking statements and risks detailed in SEC filings. Actual results may differ materially from projections.
- Potential redemption requests by SPAC shareholders might reduce available cash, impacting Pasqal’s ability to execute its business plan.
- Pasqal’s concentration of revenue in government or state-funded contracts may expose it to policy or budgetary risks.
Advisors and Legal Counsel
- Lazard Freres SAS advising Pasqal’s Board; Orrick Herrington & Sutcliffe LLP (France/US) as Pasqal’s legal counsel.
- Cantor Fitzgerald & Co. advising Bleichroeder; Reed Smith LLP (France/US) as Bleichroeder’s legal counsel.
- Cohen & Company Capital Markets acted as Lead Book-Running Manager for Bleichroeder’s IPO in January 2026.
Next Steps for Investors
- The business combination will be submitted to Bleichroeder shareholders for approval. A registration statement (Form F-4) will be filed with the SEC, including a proxy statement/prospectus.
- Investors should review all SEC filings when available, including the registration statement, proxy statement/prospectus, and announcements regarding the business combination.
- Any investment or voting decisions should be made only after careful review of these documents, as they will contain important information about the transaction.
Potential Share Price Movers
- The size and scope of the transaction (\$2B pre-money valuation, \$600M+ gross proceeds) are significant, with the potential to make Pasqal a global quantum computing leader.
- Strong revenue growth, booked contracts, and sovereign backing are likely to fuel investor optimism.
- Risks associated with approvals, market acceptance, and competition must be considered; any adverse developments could negatively impact the share price.
Disclaimer:
This article is for informational purposes only and does not constitute investment advice, solicitation, or an offer to buy or sell any securities. All information is based on publicly available sources at the date of writing and may be subject to change. Investors should review official SEC filings and consult with a financial advisor before making any investment or voting decisions. The author assumes no responsibility for actions taken based on this article.
View Bleichroeder Acquisition Corp. II Historical chart here
